New cancer clinical trial: APG-1252 in Patients With SCLC or Advanced Solid Tumors

Published on: January 01, 2018 at 10:00AM
Condition:   Small Cell Lung Cancer and Other Solid Tumors
Intervention:   Drug: APG-1252
Sponsor:   Ascentage Pharma Group Inc.
Recruiting
http://ift.tt/2lJEEc3